Urovo Technology Balance Sheet Health
Financial Health criteria checks 5/6
Urovo Technology has a total shareholder equity of CN¥1.5B and total debt of CN¥577.0M, which brings its debt-to-equity ratio to 38.2%. Its total assets and total liabilities are CN¥2.4B and CN¥934.0M respectively. Urovo Technology's EBIT is CN¥70.7M making its interest coverage ratio -5.3. It has cash and short-term investments of CN¥1.2B.
Key information
38.2%
Debt to equity ratio
CN¥577.00m
Debt
Interest coverage ratio | -5.3x |
Cash | CN¥1.21b |
Equity | CN¥1.51b |
Total liabilities | CN¥934.05m |
Total assets | CN¥2.44b |
Recent financial health updates
No updates
Recent updates
Urovo Technology (SZSE:300531) Will Want To Turn Around Its Return Trends
Jul 25Urovo Technology's (SZSE:300531) Dividend Will Be CN¥0.05
May 26Calculating The Intrinsic Value Of Urovo Technology Co., Ltd. (SZSE:300531)
Mar 27Urovo Technology Co., Ltd.'s (SZSE:300531) 27% Price Boost Is Out Of Tune With Earnings
Mar 06Capital Allocation Trends At Urovo Technology (SZSE:300531) Aren't Ideal
Feb 28Financial Position Analysis
Short Term Liabilities: 300531's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥902.5M).
Long Term Liabilities: 300531's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥31.6M).
Debt to Equity History and Analysis
Debt Level: 300531 has more cash than its total debt.
Reducing Debt: 300531's debt to equity ratio has increased from 23.2% to 38.2% over the past 5 years.
Debt Coverage: 300531's debt is well covered by operating cash flow (30%).
Interest Coverage: 300531 earns more interest than it pays, so coverage of interest payments is not a concern.